Nipocalimab was granted U.S. FDA Breakthrough Therapy Designation for the treatment of adults living with moderate-to-severe Sjögren's disease based on results from the Phase 2 DAHLIAS study ...

Researchers assessed the accuracy of CA-125 and PET/CT tests for detecting cancer among patients with idiopathic inflammatory myopathy.

Spring House, Massachusetts Wednesday, November 13, 2024, 14:00 Hrs [IST] ...